Literature DB >> 8002375

Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression.

F Puppo1, S Brenci, L Lanza, O Bosco, M A Imro, M Scudeletti, F Indiveri, S Ferrone.   

Abstract

Analysis of (sHLA-I) antigens in a large number of HIV-positive subjects found a significant increase of their level, but did not detect any change in their molecular profile. Monitoring at yearly intervals for four years of the sHLA-I antigen level in 14 HIV-positive subjects with a normal sHLA-I antigen level at study entry showed a significant correlation between progressive increase of sHLA-I antigen level and disease progression. Furthermore, a Kaplan-Meier plot of the frequency of development of AIDS in 34 patients whose cases were followed for 7 years showed that sHLA-I antigen level is a strong predictor of progression to AIDS. Its predictive value is comparable to that of serum beta 2-mu level, greater than that of serum neopterin, and lower than that of CD4+ T-cell percentage. The predictive value of sHLA-I antigen level in combination with serum beta 2-mu level, neopterin level, or CD4+ T-cell percentage is greater than that of each individual variable. These results suggest that measurement of the sHLA-I antigen level may provide useful prognostic information in HIV-positive subjects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002375     DOI: 10.1016/0198-8859(94)90025-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.

Authors:  Giuseppe Murdaca; Paola Contini; Paola Cagnati; Simona Marenco; Giulia Pieri; Francesca Lantieri; Antonino Picciotto; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-11-14       Impact factor: 3.984

2.  Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Authors:  S Migliaresi; A Bresciani; L Ambrosone; M Spera; D Barbarulo; V Lombari; G Pirozzi; G Borgia; M L Lombardi; G Tirri; C Manzo
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

Review 3.  Soluble major histocompatibility complex molecules in immune regulation: highlighting class II antigens.

Authors:  Katerina Bakela; Irene Athanassakis
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

4.  Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?

Authors:  F Puppo; A Picciotto; S Brenci; G Varagona; M Scudeletti; M Ghio; V Balestra; G Celle; F Indiveri
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

5.  Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Authors:  V Jucaud; M H Ravindranath; P I Terasaki; L E Morales-Buenrostro; F Hiepe; T Rose; R Biesen
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330

6.  Systemic inhibition of myeloid dendritic cells by circulating HLA class I molecules in HIV-1 infection.

Authors:  Jinghe Huang; Maha Al-Mozaini; Jerome Rogich; Mary F Carrington; Katherine Seiss; Florencia Pereyra; Mathias Lichterfeld; Xu G Yu
Journal:  Retrovirology       Date:  2012-01-30       Impact factor: 4.602

7.  Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients.

Authors:  G Filaci; P Contini; S Brenci; P Gazzola; L Lanza; M Scudeletti; F Indiveri; G L Mancardi; F Puppo
Journal:  Hum Immunol       Date:  1997-04-15       Impact factor: 2.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.